JMVZX
Price
$30.92
Change
-$0.05 (-0.16%)
Updated
Jul 31 closing price
Net Assets
11.16B
MVCAX
Price
$34.49
Change
-$0.11 (-0.32%)
Updated
Jul 31 closing price
Net Assets
17.38B
Interact to see
Advertisement

JMVZX vs MVCAX

JMVZX vs MVCAX Comparison Chart in %
View a ticker or compare two or three
VS
JMVZX vs. MVCAX commentary
Aug 03, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JMVZX is a Buy and MVCAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
MVCAX has more cash in the bank: 17.4B vs. JMVZX (11.2B). MVCAX pays higher dividends than JMVZX: MVCAX (1.09) vs JMVZX (0.53). JMVZX was incepted earlier than MVCAX: JMVZX (18 years) vs MVCAX (25 years). JMVZX (1.48) is less costly to investors than MVCAX (0.98). JMVZX is a more actively managed with annual turnover of: 39.00 vs. MVCAX (24.00). JMVZX has a lower initial minimum investment than MVCAX: JMVZX (0) vs MVCAX (1000). MVCAX annual gain was more profitable for investors over the last year : 11.71 vs. JMVZX (-5.46). MVCAX return over 5 years is better than : 17.90 vs. JMVZX (-23.94).
JMVZXMVCAXJMVZX / MVCAX
Total Expense Ratio1.350.97139%
Annual Report Gross Expense Ratio1.480.98151%
Fund Existence18 years25 years-
Gain YTD13.09414.69989%
Front LoadN/A6%-
Min. Initial Investment01000-
Min. Initial Investment IRAN/AN/A-
Net Assets11.2B17.4B64%
Annual Yield % from dividends0.531.0948%
Returns for 1 year-5.4611.71-47%
Returns for 3 years-4.1019.96-21%
Returns for 5 years-23.9417.90-134%
Returns for 10 years-5.6185.46-7%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PJFZX74.550.87
+1.18%
PGIM Jennison Growth Z
NRILX15.97-0.02
-0.13%
Neuberger International Sel R6
CILGX16.67-0.10
-0.60%
Clarkston Institutional
GIIZX15.87-0.12
-0.75%
GuideStone Funds Intl Eq Idx Investor
HGHSX45.84-0.38
-0.82%
Hartford Healthcare R4